For the Inventor, By the Inventor

Enter assignee name

Biocrine Ab

USPTO Granted Patents = 30

CIPO Patents = 3

EPO Patents = 11

Forward Citations = 98

Loading Chart...

Loading Chart...

15 inventors (with patents filed for the assignee):

Per-Olof Berggren (21 out of 24 patents)

Per Olof Berggren (8 out of 8 patents)

Shao-Nian Yang (6 out of 6 patents)

4. Alejandro Caicedo (4 out of 4 patents)

5. Over Cabrera (1 out of 4 patents)

6. Veit Flockerzi (1 out of 1 patent)

7. Christopher Barker (1 out of 1 patent)

8. Barbara Leibiger (1 out of 1 patent)

9. Ingo Leibiger (1 out of 1 patent)

10. Suad Efendic (1 out of 7 patents)

11. Lisa Juntti-berggren (0 patent)

12. Veit Flockerzi (0 patent)

13. Per-Olof Berggren (0 patent)

14. Per Olaf Berggren (0 patent)

15. Lisa-Juntti Berggren (0 patent)

30 patents: Sort by Forward Citations

1. 11707490 - Methods and reagents for treating diabetes (2023-07-25),

2. 11519902 - Methods for monitoring physiological status of a body organ (2022-12-06),

3. 10695425 - Methods for treating and/or limiting development of diabetes in subjects with amyotrophic lateral sclerosis (2020-06-30),

4. 10493108 - Non-invasive in vivo imaging and methods for treating diabetes (2019-12-03),

5. 10338060 - Methods for monitoring physiological status of a body organ (2019-07-02),

6. 10228364 - Methods for monitoring physiological status of a body organ (2019-03-12),

7. 10226530 - Methods for treating and/or limiting development of diabetes (2019-03-12),

8. 10207012 - Non-invasive in vivo imaging and methods for treating type I diabetes (2019-02-19),

9. 10060935 - ApoIII and the treatment and diagnosis of diabetes (2018-08-28),

10. 9968675 - Methods for treating and/or limiting development of diabetes in subjects with amyotrophic lateral sclerosis (2018-05-15),

11. 9744232 - Methods for treating and/or limiting development of diabetes (2017-08-29),

12. 9702867 - Methods for monitoring physiological status of a body organ (2017-07-11),

13. 9700617 - Methods for treating and/or limiting development of diabetes in subjects with amyotrophic lateral sclerosis (2017-07-11),

14. 9463205 - Non-invasive in vivo imaging and methods for treating type I diabetes (2016-10-11),

15. 9462973 - Methods for monitoring physiological status of a body organ (2016-10-11),

Biocrine AB is a biotechnology company focused on the development and commercialization of innovative treatments for hormonal disorders. Our mission is to improve patients' lives through the discovery and development of effective and safe therapeutics. With a team of dedicated scientists and cutting-edge research facilities, we are committed to advancing scientific knowledge and translating it into novel therapeutic solutions. Visit our website to learn more about our company and ongoing research projects.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

30 Patents

#9 in Solna

#207 in Sweden

#21,168 in the World

Biocrine Ab

Forward Citations = 98

15 inventors:

Per-Olof Berggren (21 out of 24 patents)

Per Olof Berggren (8 out of 8 patents)

Shao-Nian Yang (6 out of 6 patents)

4. Alejandro Caicedo (4 out of 4 patents)

5. Over Cabrera (1 out of 4 patents)

Please report any incorrect information to support@idiyas.com

Loading…